Response by Stepanian and Jaffe to Letters Regarding Article, “Ponatinib, but Not the New Abl-Kinase Inhibitor Asciminib, Activates Platelets, Leukocytes, and Endothelial Cell TNF Signaling to Induce Atherosclerotic Plaque Inflammation, Myocardial Infarction, and Stroke”

A Alec Stepanian (Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA. Graduate School of Biomedical Sciences, Tufts School of Medicine, Boston, MA.) I Iris Z. Jaffe (Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA. Graduate School of Biomedical Sciences, Tufts School of Medicine, Boston, MA.)

Article Details

Journal Circulation
Volume / Issue Vol. 153, Issue 14
Published April 07, 2026
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (2)

A

Alec Stepanian

Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA. Graduate School of Biomedical Sciences, Tufts School of Medicine, Boston, MA.

I

Iris Z. Jaffe

Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA. Graduate School of Biomedical Sciences, Tufts School of Medicine, Boston, MA.